Implementation of HPV testing in Latin America

Journal of Clinical Virology

Volumn 76, Issue , 2016, Pages S69-S73

  Jeronimo, Jose ^a   Holme, Francesca ^a   Slavkovsky, Rose ^a   Camel, Claudia ^b  

^a PATH   (United States)

^b Edificio Valsari   (Guatemala)

Author keywords

Cancer prevention; Cervical cancer; HPV testing; Latin America; Self sampling

Indexed keywords

ARGENTINA; DIAGNOSTIC PROCEDURE; HUMAN; HUMAN PAPILLOMAVIRUS TEST; MEXICO; NICARAGUA; NONHUMAN; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUALITY CONTROL; REVIEW; SCREENING TEST; SOUTH AND CENTRAL AMERICA; VIRUS DETECTION; CERVICAL INTRAEPITHELIAL NEOPLASIA; CLASSIFICATION; COLPOSCOPY; COMPLICATION; EARLY CANCER DIAGNOSIS; ECONOMICS; FEMALE; GENETICS; GENOTYPING TECHNIQUE; GOVERNMENT; HUMAN PAPILLOMAVIRUS DNA TEST; ISOLATION AND PURIFICATION; MASS SCREENING; ORGANIZATION AND MANAGEMENT; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PROCEDURES; UTERINE CERVICAL NEOPLASMS; VAGINA SMEAR;

CERVICAL INTRAEPITHELIAL NEOPLASIA; COLPOSCOPY; EARLY DETECTION OF CANCER; FEMALE; GENOTYPING TECHNIQUES; GOVERNMENT PROGRAMS; GUIDELINES AS TOPIC; HUMAN PAPILLOMAVIRUS DNA TESTS; HUMANS; LATIN AMERICA; MASS SCREENING; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 84960357992     PISSN: 13866532     EISSN: 18735967     Source Type: Journal    
DOI: 10.1016/j.jcv.2015.11.035     Document Type: Review

References (16)

1. Torre L.A., Bray F., Siregel R.L., Ferlay J., Lortet-Tieulent J., Jemal A. Global cancer statistics. CA Cancer J. Clin. 2015, 65(2):87-108.
2. Munoz N., Castellsague X., de Gonzalez A.B., Gissmann L. Chapter 1: HPV in the etiology of human cancer. Vaccine 2006, 24(Suppl. 3):S1-S10.
3. Gustafsson L., Ponten J., Bergstrom R., Adami H.O. International incidence rates of invasive cervical cancer before cytological screening. Int. J. Cancer 1997, 71(2):159-165.
4. Murillo R., Almonte M., Pereira A., Ferrer E., Gamboa O.A., Jeronimo J., Lazcano-Ponce E. Cervical cancer screening programs in Latin America and the Caribbean. Vaccine 2008, 26(Suppl. 11):L37-L48.
5. Mayrand M.H., Duarte-Franco E., Rodrigues I., Walter S.D., Hanley J., Ferenczy A., Ratnam S., Coutlée F., Franco E.L., Canadian Cervical Cancer Screening Trial Study Group Human papillomavirus DNA versus papanicolaou screening tests for cervical cancer. N. Engl. J. Med. 2007, 357(16):1579-1588.
6. Terrazas S., Ibáñez C., Lagos M., Poggi H., Brañes J., Barriga M.I., Cartagena J., Núñez F., González F., Cook P., Van De Wyngard V., Ferreccio C. Human papillomavirus testing in cervical cancer screening at a public health service of Santiago, Chile. Rev. Med. Chile 2015, 143(1):56-62.
7. Almonte M., Ferreccio C., Winkler J.L., Cuzick J., Tsu V., Robles S., Takahashi R., Sasieni P. Cervical screening by visual inspection, HPV testing, liquid-based and conventional cytology in Amazonian Peru. Int. J. Cancer 2007, 121(4):802.
8. Jeronimo J., Bansil P., Lim J., Peck R., Paul P., Amador J.J., Mirembe F., Byamugisha J., Poli U.R., Satyanarayana L., Asthana A., START-UP Study Group A multicountry evaluation of careHPV testing, visual inspection with acetic acid, and papanicolaou testing for the detection of cervical cancer. Int. J. Gynecol. Cancer 2014, 24(3):576-585.
9. Khan M.J., Castle P.E., Lorincz A.T., Wacholder S., Sherman M., Scott D.R., Rush B.B., Glass A.G., Schiffman M. The elevated 10-year risk of cervical precancer and cancer in women with human papillomavirus (HPV) type 16 or 18 and the possible utility of type-specific HPV testing in clinical practice. J. Natl. Cancer Inst. 2005, 97(14):1072-1079.
10. Bansil P., Wittet S., Lim J.L., Winkler J.L., Paul P., Jeronimo J. Acceptability of self-collection sampling for HPV-DNA testing in low-resource settings: a mixed methods approach. BMC Public Health 2014, 14:596.
11. Lazcano-Ponce E., Lorincz A.T., Torres L., Salmeron J., Cruz A., Rojas R., Hernandez P., Hernandez M. Specimen self-collection and HPV DNA screening in a pilot study of 100,242 women. Int. J. Cancer 2014, 135(1):109-116.
12. Hernandez-Marquez C.I., Salinas-Urbina A.A., Cruz-Valdez A., Hernandez-Giron C. Conocimientos sobre virus del papiloma humano (VPH) y aceptación de auto-toma vaginal en mujeres mexicanas. Rev. Salud Pública 2014, 16(5):697-708.
13. Arrossi S., Thouyaret L., Laudi R., Marín O., Ramírez J., Paolino M., Herrero R., Campanera A. Implementation of HPV-testing for cervical cancer screening in programmatic contexts: the Jujuy demonstration project in Argentina. Int. J. Cancer 2015, 137(7):1709-1718.
14. Arrossi S., Thouyaret L., Herrero R., Campanera A., Magdaleno A., Cuberli M., Barletta P., Laudi R., Orellana L., EMA Study team Effect of self-collection of HPV DNA offered by community health workers at home visits on uptake of screening for cervical cancer (the EMA study): a population-based cluster-randomised trial. Lancet Global Health 2015, 3(2):e85-e94.
15. World Health Organization (WHO) WHO Guidelines for Screening and Treatment of Precancerous Lesions for Cervical Cancer Prevention 2013, WHO, Geneva.
16. Cervical Cancer Action (CCA) Progress in Cervical Cancer Prevention: The CCA Report Card 2015 2015, CCA, Seattle, Available at: www.cervicalcanceraction.org/pubs/CCA_reportcard_low-res_2015.pdf. (Accessed: 07.11.15).